Cervical cancer presents a significant global health burden, with an estimated 266 000 deaths and 528 000 new cases worldwide recorded in 2012. Approximately 85% of cervical cancer cases occur in developing countries and they comprise 12% of all female cancers. Human papillomavirus (HPV) is necessary, but not sufficient for cervical cancer, and it is also a factor in vaginal, vulval, anal, penile and oropharyngeal cancers.
Subtypes 16 and 18 (HPV-16 and HPV-18) have been found to be the most pathogenic of the high-risk HPV types. Indeed together they account for 70-80% cervical cancers, 40-50% of vulval and oropharyngeal cancers and 70-80% of anal cancers.
Information data for underdeveloped countries has not been reported which we undertake alongside are other face of the campaigns to introduce the awareness for women in the highest age range group.
Having your regular smear test (also known as cervical screening) is a very important part of being a woman.
Cervical screening isn't a test for cancer; it's a test to check the health of the cells of the cervix. Most women's test results show that everything is normal, but for around 1 in 20 women the test shows some abnormal changes in the cells of the cervix.
In some cases, the abnormal cells need to be removed so they can't become cancerous.